Effects of single or repeated silymarin administration on pharmacokinetics of risperidone and its major metabolite, 9-hydroxyrisperidone in rats
Authors:
- 30 August 2012
- journal article
- Published by Taylor & Francis in Xenobiotica
- Vol. 43 (3) , 303-310
Abstract
1. The interactions between herbal dietary supplements and therapeutic drugs have emerged as an important issue and P-glycoprotein (P-gp) has been reported as one of the significant factors of these interactions. 2. The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a P-gp substrate, risperidone, and its major metabolite, 9-hydroxyrisperidone, in rats. 3. To determine the plasma levels of risperidone and 9-hydroxyrisperidone in rats, a HPLC method was developed using a liquid-liquid acid back extraction. When risperidone (6 mg/kg) was co-administered with silymarin (40 mg/kg) to rats orally, the Cmax of 9-hydroxyrisperidone was significantly increased to1.3-fold (p < 0.05), while the other pharmacokinetic parameters did not show any significant differences. Expanding the experiment where rats were repeatedly administered with silymarin for 5 days prior to giving risperidone, the Cmax of risperidone and 9-hydroxyrisperidone were significantly increased to 2.4-fold (p < 0.001) and 1.7-fold (p < 0.001), respectively, and the AUC0-t, as well to 1.7-fold (p < 0.05) and 2.1-fold (p < 0.01), respectively. 4. The repeated exposures of silymarin, compared to single administration of silymarin, increased oral bioavailability and affected the pharmacokinetics of risperidone and 9-hydroxyrisperidone, by inhibiting P-gp.Keywords
This publication has 33 references indexed in Scilit:
- Silybin and Silymarin - New and Emerging Applications in MedicineCurrent Medicinal Chemistry, 2007
- The effect of verapamil on the pharmacokinetics of paclitaxel in ratsEuropean Journal of Pharmaceutical Sciences, 2005
- Coadministration of Milk Thistle and Indinavir in Healthy SubjectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- The role of multidrug transporters in drug availability, metabolism and toxicityToxicology Letters, 2003
- In vitro P-glycoprotein affinity for atypical and conventional antipsychoticsLife Sciences, 2002
- Role of transport proteins in drug absorption, distribution and excretionXenobiotica, 2001
- P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugsInt. Journal of Clinical Pharmacology and Therapeutics, 2000
- Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P 4503A4AAPS PharmSci, 1999
- Plasma Concentrations of Risperidone and its 9-Hydroxy Metabolite and their Relationship to Dose in Schizophrenic Patients: Simultaneous Determination by a High Performance Liquid Chromatography with Electrochemical DetectionPharmacopsychiatry, 1998
- Antidepressant Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995